Vital Signs - Perspectives in Oncology Drug Delivery
Vital Signs - Perspectives in Oncology Drug Delivery
RELEASE DATE
18-Jan-2010
18-Jan-2010
REGION
North America
North America
Research Code: 9561-00-9E-00-00
SKU: HC00587-NA-MR_04060
$1,500.00
Special Price $1,125.00 save 25 %
In stock
SKU
HC00587-NA-MR_04060
Description
This issue of Vital Signs, released on January 18, 2010, provides a strategic overview of trends in MD, nurse and cancer patient feedback about drug delivery and treatment in oncology, as well as the value sought from this area from multiple facets of the pharma industry. Additionally, a company spotlight is provided for Cure DM, a biopharmaceutical company established to develop new therapies that may prevent, ameliorate or reverse diabetes and allow for the discontinuation of insulin therapy. Reimbursement and regulatory news from the FDA is also provided for the week of December 28, 2009.
Table of Contents
This week's issue:
Related Research
Popular Topics
This issue of Vital Signs, released on January 18, 2010, provides a strategic overview of trends in MD, nurse and cancer patient feedback about drug delivery and treatment in oncology, as well as the value sought from this area from multiple facets of the pharma industry. Additionally, a company spotlight is provided for Cure DM, a biopharmaceutical company established to develop new therapies that may prevent, ameliorate or reverse diabetes and allow for the discontinuation of insulin therapy. Reimbursement and regulatory news from the FDA is also provided for the week of December 28, 2009.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9561-00-9E-00-00 |
Is Prebook | No |